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1. Introduction
Mycobacteria from the Mycobacterium avium complex (MAC) cause a variety of diseases in‐
cluding tuberculosis-like disease in humans and birds, disseminated infections in AIDS pa‐
tients and otherwise immunocompromised patients, lymphadenitis in humans and
mammals and paratuberculosis in ruminants. M. avium subsp. paratuberculosis (Map) is the
etiologic agent of Johne´s disease in cattle and it has been identified in human patients with
Crohn’s disease. The MAC comprises slow growing mycobacteria that are ubiquitous in the
environment (soil and water), and have a wide source range, causing disease in various do‐
mestic and wild mammals and birds [1].
The aim of this study was to discuss the classification and biology, epidemiology, clinical
signs, pathology, diagnostic techniques, and public health concerns in Mycobacterium avium
complex in domestic and wild animals.
2. Classification and biology of Mycobacterium avium complex
The phylum Actinobacteria is large and very complex; it contains one class (Actinobacteria),
five subclasses, six orders, 14 suborders, and 40 families. The orders, suborders, and families
are defined based on 16S rRNA sequences and distinctive signature nucleotides. The subor‐
der Corynebacterineae contains seven families with several well-known genera. Three of the
most important genera are Corynebacterium, Mycobacterium, and Nocardia [2].
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The species of Mycobacterium, sole genus of the family Mycobacteriaceae, is composed of a
group of high genomic C+G content (~61 to 71%), facultative intracellular, Gram-positive
microorganisms comprising more than 130 established and validated species and subspecies
[3], with surprisingly diverse phenotypes related to growth rate, metabolic activity, colony
appearance, environmental distribution, and pathogenic potential for eukaryotic hosts [4].
Although most of these species are saprophytic, important human and animal pathogens
have been identified. Pathogenic members are usually characterized by their slow growth in
culture, with generation times of 12 to 24 h, and must be incubated for 2 to 40 days after
inoculation of a solidified complex medium to form a visible colony, whereas nonpathogen‐
ic members grow considerably faster [5]. Mycobacteria are acid-fast bacilli, acidophilic,
small, slightly curved or straight rods that sometimes branch or form filaments. Mycobacte‐
rial filaments differ from those of actinomycetes in readily fragmenting into rods and coc‐
coid bodies when distributed. They are aerobic, immobile, non-sporulated and catalase
positive bacteria. Their cell wall is lipid-rich and contain waxes with 60 to 90 carbon mycolic
acids, which are complex fatty acids with a hydroxyl group on the β-carbon and an aliphatic
chain attached to the α-carbon. The presence of mycolic acids and other lipids, in high con‐
centration outside the peptidoglycan, makes mycobacteria acid-fast dye resistant (basic
fuchsin cannot be removed from the cell by acid alcohol treatment), as well as resistant to
immune system defense mechanisms and disinfectants [2,6].
2.1. Mycobacterium avium complex (MAC)
Bacteria from the Mycobacterium avium complex (MAC) differ in virulence and ecology, and
are the most frequently isolated non-tuberculous mycobacteria [7]. Mycobacterium members
of MAC have the capacity to survive and multiply under a wide range of environmental
conditions, including low pH, extreme temperatures, chlorine or ozone treatment and low
oxygen level. Thus, plus their ability to utilize many substances as nutrients, enables them to
grow successfully in many biotopes [1]. The environmental sources responsible for MAC in‐
fection in different populations, the specific routes of infection and transmission, the poten‐
tial for latent infection and reactivation of disease are not yet well defined [4,8]. Ingestion of
environmental organisms followed by invasion through the gastrointestinal tract has been
suggested as the main route of infection because the organisms are frequently isolated from
stools of different animals. There is also an important positive correlation between the pres‐
ence of MAC in respiratory samples and the subsequent development of disseminated dis‐
ease [9]. Traditionally, MAC includes two species, Mycobacterium avium and Mycobacterium
intracellulare [3]. Recently, advances in molecular taxonomy have fuelled identification of
novel species within the MAC, including the Mycobacterium chimaera incorporating sequevar
MAC-A organisms isolated from humans with pulmonary cavitations, pulmonary abscess,
chronic obstructive pulmonary disease and bronchiectasis [10]; the Mycobacterium colom‐
biense incorporating sequevar MAC-X organisms isolated from the blood and sputum of
HIV infected patients in Colombia [11], and from diseased lymph nodes in children [12,13];
the Mycobacterium arosiense, recently described in an immunocompromised child with disse‐
minated osteomyelitic lesions [14]; the Mycobacterium vulneris [15], Mycobacterium marseil‐
lense, Mycobacterium timonense and Mycobacterium bouchedurhonense isolated from patients
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with pulmonary disease. On the basis of genotypic, phenotypic and growth characteristics,
biochemical tests and historical reasons, multiple subspecies of Mycobacterium avium are rec‐
ognized. These include the subsp. avium, subsp. paratuberculosis, subsp. hominissuis and
subsp. silvaticum [3]. All four Mycobacterium avium subspecies and Mycobacterium intracellu‐
lare are capable of infecting a diverse range of host and possess a high degree of genetic sim‐
ilarity [17]. Contemporary methods for MAC identification, e.g., high performance liquid
chromatography (HPLC) of cell wall mycolic acids and genetic probes based on rRNA tar‐
gets, e.g. AccuProbe, cannot discriminate among Mycobacterium avium subspecies. Given the
differences in pathogenicity among Mycobacterium avium subspecies and the implications re‐
garding the infection source, a practical and accurate method of simply identifying Mycobac‐
terium avium subspecies is needed [18].
2.2. Mycobacterium avium subsp. avium
Before establishing the Mycobacterium avium subsp. avium (Maa) designation, this bacterium
was simply referred to as Mycobacterium avium and has long been recognized as a primary
pathogen causing avian tuberculosis in wild and domestic birds as well as in a variety of fowl,
game birds and water-fowl. The most common route of infection for susceptible animals is the
alimentary tract. Respiratory tract is also suggested as a potential source of infection [19].
2.3. Mycobacterium avium subsp. paratuberculosis
Mycobacterium avium subsp. paratuberculosis (Map) is the etiologic agent of Johne’s disease or
paratuberculosis, a chronic granulomatous enteritis of ruminant livestock and wildlife, with
worldwide distribution having a significant impact on the world economy [5]. For veterina‐
ry medicine, Map is the MAC member of greatest importance, and is capable of infecting
and causing disease in a wide array of animal species, including nonhuman primates, with‐
out the need for co-existent immunosuppressive infections [18]. Map is one of the slowest
growing mycobacterial species, hence primary isolation from specimen, requires prolonged
culture incubation and can take several months. Unlike most other Mycobacterium avium sub‐
species, isolation of Map requires the addition of the siderophore mycobactin to culture me‐
dia [20]. From phenotypic analysis, the Map group has been subdivided into two main
types, bovine and ovine, that vary in hosts, diseases caused, and growth phenotypes [21].
Genotypically, these findings were based primarily on comparisons of the integration loci of
the IS900 insertion sequence (IS) and used polymorphisms in IS1311 to separate sheep and
cattle isolates into separate populations [22].
2.4. Mycobacterium avium subsp. hominissuis
MAC isolates of genotypes IS901- and IS1245+ and serotypes 4 to 6, 8 to 11 and 21 are less
virulent for birds and are designated M. avium subsp. hominissuis (Mah). Mah was proposed
to distinguish organisms found in humans and pigs from those isolated from birds [3].
Those are genomically diverse, the more diverse group of strains, low-virulence, opportun‐
istic pathogens for both animals and humans [18]. Considered ubiquitous in the environ‐
ment (the most likely source of infection for humans), Mah can cause serious systemic
Mycobacterium avium Complex in Domestic and Wild Animals
http://dx.doi.org/10.5772/54323
93
infection in immunocompromised patients, such as those infected with HIV. Additionally,
this opportunistic pathogen can cause cervical lymphadenitis in children with cystic fibrosis,
and lung infections in patients with underlying lung disease [23]. Domestic water distribu‐
tion systems have been reported as possible sources of Mah infections in hospitals, family
houses, and commercial places [24]. In animals, Mah is found as a cause of lymphadenitis of
the head and mesenteric lymph nodes of swine documented at slaughter [18], and can also
lead to systemic infection of parenchymatous organs [23]. Mah were recovered from affected
lymph nodes of red deer from Austria [25].
2.5. Mycobacterium avium subsp. silvaticum
Mycobacterium avium subsp. silvaticum applies to the previously named wood pigeon bacil‐
lus, an acid-fast organism causing tuberculosis-like lesions in these wood pigeons. The in‐
ability to grow on egg media, the stimulation of growth by pyruvate and at pH 5.5 and their
mycobactin dependency upon primary isolation, gradually losing this phenotype upon sub‐
culture, have been described as characteristics of Mycobacterium avium subsp. silvaticum [17].
2.6. Mycobacterium intracellulare
Mycobacterium intracellulare, initially named Nocardia intracellularis, is an environmental organ‐
ism and opportunistic pathogen, isolated from a variety of animal hosts and environmental
sources. Mycobacterium intracellulare is a closely related pathogen of birds with a lower preva‐
lence [26]. In general, it has been subject to less study than Mycobacterium avium, as the latter is
more prevalent in clinical and environmental samples, has a wider apparent host range, and
contributes almost exclusively to disseminated MAC disease in human immunodeficiency vi‐
rus patients [3]. The type strain of Mycobacterium intracellulare (ATCC 13950) was isolated from
a human, specifically responsible for enlarged lymph nodes in children, who died from disse‐
minated disease [3], and progressive pulmonary disease in elderly women [27]. Mycobacterium
intracellulare appears to have a distinct ecological niche, more prevalent in biofilms and at sig‐
nificantly higher CFU numbers than Mycobacterium avium [28].
3. Clinical signs and morphology in domestic and wild species
All ruminant species, captive or free-ranging, are susceptible to disease and death due to
MAC infection [29], and a wide diversity of non-ruminant species can become infected with
mycobateria belonging to MAC, especially with Map and Maa. Paratuberculosis has been de‐
scribed in cattle, small ruminants, deer, and in South American camelids (llamas and alpa‐
cas) [30,31]. This chronic disease is one of the most serious affecting dairy cattle worldwide
showing symptoms of an insidious intestinal pathology responsible for significant economic
losses [5]. The close relationship between wild, captive and domestic ruminants and other
species like birds is, nowadays, clinically relevant as the wild population could act as reser‐
voir for this agent [32].
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In cattle this disease is scored in four stages according to its evolution and symptoms, two of
them evolving sub-clinically. Stage I, or silent infection, is the most observed in young ani‐
mals, without significant clinical signs and only in post mortem evaluation it is possible to
identify the agent by culture or histopathology analysis [33].
Stage II remains a subclinical disease, being observed in adult animals. It may be detected
by alterations in immunological serological and/or cellular parameters. Intermittently, fecal
culture and histopathology analysis of these animals could be positive to Map [33].
In stage III the clinical signs can be observed, occurring after several years of incubation. The
initial clinical signs are subtle with gradual weight loss despite normal appetite, intermittent
diarrhea along several weeks, drop in milk production and roughness of hair coat. These
symptoms are included in the differential diagnosis of multiple diseases, so it is often mis‐
diagnosed [34]. Usually, animals in this stage are positive upon ELISA and other serological
tests, as for histopathological analysis of lesions, which are common in the terminal ileum
[35] (Figure 2A).
The last stage of the disease (stage IV) comprises animals that rapidly progress from the
stage III with rapid condition deteriorated. They became increasingly lethargic, weak and
emaciated and present intermandibular edema due to hypoproteinemia. In this stage, the
culture of the agent, molecular biology techniques of PCR, ELISA, serology and histopathol‐
ogy (Figure 1), all are positive for the majority of animals tested. The gastrointestinal tract is
the preferential local to sample in order to isolate the agent, but in some conditions it can
even be present in extraintestinal lesions, with the liver and lymph nodes being the most
common sites [33].
Figure 1. Morphological aspects of paratuberculosis lesions in the ileum of sheep. A- Thickening of the mucosa by an
inflammatory infiltrate composed by epithelioid cells, macrophages and some multinucleated giant cells. (H&E stain,
Bar=50μm) B- Acid-acohol resistant bacilli within the macrophages and epithelioid cells that infiltrate the mucosa. No‐
tice the abundant number of mycobacteria that are visible at moderate amplification (Ziehl-Neelsen, Bar=30μm)
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3.1. Clinical signs and lesions in wild species
Mycobacteria belonging to the MAC can affect a wide-range of wild animals, but little has
been published on the clinical signs, which are rarely perceived or not documented. When
present, the occurrence of clinical signs and lesions is highly variable in timing but often
similar to those of their domesticated counterparts. The vast majority of reports on MAC
species affecting wildlife mention the Map and the Maa as the mycobacteria most commonly
isolated in these animals.
3.1.2. Wild ruminants
The lesions observed in wild species of sheep and goats are identical to those of their domes‐
tic counterparts, while in the South American camelids the lesional pattern is similar to that
of cattle. However in llamas and alpacas, in contrast to what is generally described in cattle,
lymph node necrosis and mineralization, along with multiorganic dissemination, have also
been reported [30,31]. As in the previously mentioned species, the most significant MAC
species capable of causing clinical disease in free-living, captive and farmed deer are Map
and Maa. Although Mah has been also isolated from lesions in deer [25,26] and Mycobacteri‐
um intracellulare was also found in deer species but they are not so common and it’s infection
is usually subclinical. Despite the occurrence of paratuberculosis in adults, outbreaks of the
disease frequently occur in young deer of 8-15 months of age, contrary to the clinical disease
in sheep and cattle which usually affects adults of 3-5 years of age [36]. Clinical signs of par‐
atuberculosis in deer are similar to those described in sheep and cattle, with diarrhea and
loss of weight and body condition [37]. Accordingly, the intestinal lesions of paratuberculo‐
sis in deer primarily affect the jejunum and ileum, and are identical to the typical lesions ob‐
served in sheep and goats [30]; yet, necrosis and mineralization in lymph nodes draining the
gastrointestinal tract, especially those draining the ileum and ileocecal valve, are a common
feature (Figure 2B). The lymph nodes are often enlarged, and a range of changes from yel‐
low watery areas to caseous necrosis is observed on cut surfaces. The histologic changes in
these lesions are very similar to those caused by Mycobacterium bovis and other members of
the MAC genus [38,39]. Balseiro et al., have proposed an histopathological classification of
lesions observed in natural occurring cases of paratuberculosis in free-ranging fallow deer
(Dama dama), according to which the lesions would be graded into four categories: focal,
multifocal, diffuse multibacillary, and diffuse intermediate (multibacillary-lymphocytic) le‐
sions. Focal lesions are composed of small granulomas, mainly in the jejunal and ileal lymph
nodes, whereas multifocal lesions consist in well-demarcated granulomas in the intestinal
lymphoid tissue and also in the intestinal lamina propria. Diffuse multibacillary lesions are
characterized by a severe granulomatous enteritis and lymphadenitis. Macrophages and nu‐
merous Langhan’s multinucleatd giant cells (L-MGC) containing many mycobacteria are
present, resulting in macroscopic changes in the normal gut morphology. These changes are
found from the proximal jejunum to the ileocaecal valve, but lesions are always particularly
severe in the distal jejunum. In the diffuse intermediate (multibacillary-lymphocytic) lesions,
there is a prominence of lymphocytes, macrophages and L-MGC, with small numbers of
mycobacteria [40]. In deer with clinical signs of paratuberculosis, disseminated granuloma‐
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tous lesions in the lung and liver can also be observed [38]. A recent report in free-ranging
red deer (Cervus elaphus) supports the possibility of multiorganic dissemination of Map in
deer, since the agent was isolated from kidneys with granulomatous lesions [41].
Figure 2. A – Paratuberculosis gross lesions in the ileum of sheep. Notice the increased thickness of the mucosa, with
the characteristic folds and gyros B – Paratuberculosis lesions in the submandibularis lymph nodes of red deer (Cervus
elaphus) with caseous necrosis.
Figure 3. A - Morphological aspects of paratuberculosis lesions in the kidneys of deer (Cervus elaphus). A single granu‐
loma with central caseous necrosis, surrounded by a thick fibrous capsule (H&E 100μm). B – Higher magnification of
the previous image. Notice the presence of Langhan’s MGC (Arrow. H&E 50μm).
In deer,  the infection by Maa  is  self-limiting as in other mammalian species [36,42].  The
lesions may be purulent,  caseous,  or granulomatous [26],  and are mainly present in the
retropharyngeal  lymph nodes and lymph nodes draining the intestinal  tract  (mesenteric
and  ileocaecal),  consistent  with  the  feco-oral  route  of  infection.  The  granulomatous  le‐
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sions are grossly and histologically identical to the lesions caused by Mycobacterium bovis
[42].  Mah  lesions  in  deer  are  similar  to  those  observed  in  animals  with  Maa  infection,
and  although  rare,  both  mycobacteria  can  cause  systemic  disease  [26]  with  hematoge‐
nous spread to the liver and lungs to produce miliary lesions and a terminal septicemia
[43].  Despite  of  these  findings,  Map  and  Maa  infections  can  be  present  in  apparently
asymptomatic deer herds [44,45].  Furthermore,  a study of wild Tule elks (Cervus elaphus
nannodes)  from  California  revealed  no  significant  associations  between  MAC  infection
and  microscopic  lesions,  such  as  presence  of  macrophages  and/or  multinucleate  giant
cells (MGC) in tissue sections [45] (Figure 3).
3.1.3. Non-ruminant species
Map  has  been  isolated  in  a  wide  range  of  wild  mammals,  from  rodents,  badgers,  ra‐
coons,  nine-banded  armadillos,  opossums,  northern  short-tailed  shrew,  striped  skunks
[46-48],  wild boars [32,49]  and rhinoceros [50]  to bears [51],  but not all  of  them present
the  same susceptibility  and develop clinical  signs  or  lesions  when infected.  The  lesions
produced by Map,  representative or not of paratuberculosis,  as well  as the clinical signs
seen  in  non-ruminant  wild  animals  are  more  subtle  than  those  observed  in  wild-rumi‐
nant species. Monkeys (Macaca arctoides and Papio sphinx) have demonstrated susceptibili‐
ty to Map  infection and develop lesions that are confined to the intestine and abdominal
lymph nodes, resembling the lesions of paratuberculosis in cattle and in humans Crohn’s
disease [52,53].  When infected by Map  lagomorphs produce an intestinal  disease similar
to paratuberculosis  in ruminants,  and severe infection can occur naturally,  in which ex‐
tensive granulomas with numerous giants’ cells carrying multiple acid-fast bacilli  can be
observed in  the  small  intestine  [54].  In  foxes  and stoats,  Map  affects  the  intestines  and
mesenteric  lymph  nodes  with  microscopic  changes  similar  to  those  described  in  rumi‐
nants with subclinical paratuberculosis. The lesions are composed of single macrophage-
like  cells  or  discrete  granulomas  consisting  of  small  numbers  of  macrophages,  in  the
cortex  and  paracortex  of  the  mesenteric  lymph  nodes.  In  the  small  intestine,  only  few
numbers of intracellular acid-fast bacteria are present within the macrophages, and Lan‐
ghan’s-type MGC, irregularly scattered in the granulomas, in all  layers of affected intes‐
tine  [46,54,55].  The  typical  pathology  of  paratuberculosis  has  also  been  noted  in  wood
mice,  weasels,  badgers  [46],  and  rats  infected  with  the  predominant  ruminant  strains
[56].  When present,  in  brushtail  possum and hedgehogs  infected  with  Map,  the  lesions
observed are in the grastrointestinal  tract  [57].  A recent  report  revealed that  wild Eura‐
sian  otters  (Lutra  lutra  L.)  could  be  infected  with  Map.  In  that  study,  no  gross  lesions
were  found,  but  the  retropharyngeal  and  mesenteric  lymph  nodes  presented  disrupted
architecture, lymphoid depletion and diffuse inflammatory infiltrate composed mainly of
macrophages  and,  to  a  lesser  extent,  neutrophils.  Map  was  identified  by  direct  PCR in
several organs, including the intestine and lymph nodes [58]. Reports in which Map  was
isolated from Eurasian wild boars (Sus scrofa)  revealed that the infection can occur with
or without lesions, the later being the most frequent. If present, lesions generally consist
of  granulomatous  enteritis  and  mesenteric  lymphadenitis  [32,49].  In  mesenteric  lymph
nodes, lymphadenitis with multifocal lesions ranging from less than 1 cm to large areas
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of more than 1 cm in diameter, of either necrotic or necrotic calcified granulomas are ob‐
served (Figure 4).  The presence of lymphocytes and caseous necrosis are the most com‐
mon findings in these lesions [59].
Figure 4. Morphological aspects of paratuberculosis lesions in wild boar (Sus scrofa). Presence of of multiple granulo‐
mas in the mesenteric lymph nodes (H&E 50μm). A – Notice the caseous necrosis surrounded by inflammatory cells
predominantly macrophages and some fibroblasts. B – Higher magnification of the former image. Note the Langhan’s
MGC (Arrows. H&E 50μm).
Despite Maa being widely reported in wild boar, data on clinical infection or mortality are
scarce [49]. Apparently, natural infection with this mycobateria causes barely detectable
clinical signs or lesions [49]. However, there are reports of Maa isolated from free-ranging
Eurasian wild boars with tuberculous lesions in intestinal lymph nodes [60], and the experi‐
mental infection with high doses of Maa results in gross and histopathological lesions of tu‐
berculosis in tracheobronchial and mandibular lymph nodes. All visible lesions are less than
10 mm in diameter and consist of typical tuberculous granulomas with a central caseous ne‐
crosis, variably mineralized, surrounded by macrophages, lymphocytes, neutrophils, eosi‐
nophils and occasional MGC surrounded by fibrous tissue. Acid-fast bacilli are rarely
detected in the necrotic debris of these lesions [61]. Another study also showed that in wild
boars with mesenteric and submaxillar lymphadenitis, Mycobacterium avium subspecies type
1 and M. avium subspecies type 2 were the most frequently isolated mycobacteria [62].
Regarding Mah in wild boar, recent reports suggest that this animal species may act as a res‐
ervoir for these mycobacteria, since it was detected in lymph nodes without gross lesions or
microscopic lesions [60,63].
3.2. Bird species
Bird species, either domestic or free-living can be infected with MAC mycobacteria, but they
are more susceptible to Maa, the causative agent of avian tuberculosis [19]. Infection by M.
avium subsp. paratuberculosis has been also documented in birds, with and without clinical
and pathological findings [46,57].
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Maa belonging to serotypes 1, 2, 3, and 6 is the most common agent of avian tuberculosis,
but other species belonging to MAC, such as M. intracellulare, are also sporadic causes of dis‐
ease [19]. Tuberculosis affects a wide-range of bird species, and it has been documented in
waterfowl, galliformes, columbiformes, passerines, psittacines, raptors, and ratites [64-67].
According to their susceptibility to the disease, it has been proposed the classification of bird
species into four groups, from highly susceptible to highly resistant: (1) domestic fowl, spar‐
rows, pheasants, and partridges; (2) guinea fowl and domestic turkeys; (3) domestic goose
and duck; (4) domestic pigeon [19]. The clinical signs of avian tuberculosis are well estab‐
lished but are not pathognomonic, and are different according to the phase of infection and
the predominant form of the disease in the bird species, which in turn is related to the spe‐
cies susceptibility to the agent. Avian tuberculosis usually presents three stages or phases:
latency, lesion development, and period of cachexia [68,69]. In most reports on the initial
phase of avian tuberculosis the absence of clinical signs is a common feature. On the contra‐
ry, in advanced cases, progressive weight loss, depression, white diarrhea with soiled feath‐
ers, increased thirst, respiratory distress, fatigue, and decreased egg production may be
observed [68]. Generally, avian tuberculosis is an intestinal and hepatic disease that can dis‐
seminate to other organs including the lungs, air sacs, spleen, bone marrow, and skin [69].
This is considered as the classical form of infection, and it’s marked by the presence of tuber‐
cles or granulomas in multiple organs. Lesions in the intestinal tract characterize a second
form of infection, and a third type of infection, especially reported finches, canaries, and
psittacines occurs without the development of tuberculous lesions [19,68,69]. The clinical
signs of the intestinal form of tuberculosis are characterized by chronic wasting disease. In
severe cases and as disease progresses, feathers are often dull or ruffled and comb, wattle,
and earlobes are paler, thinner and dry. Birds become lethargic and emaciated with marked
atrophy of breast muscles, displaying the typical “knife edged” keel. In extreme cases, the
body fat disappears, and the bird’s face looks smaller than normal. The body temperature of
the affected birds remains normal, even in severe cases [68,69]. Sudden death may also oc‐
cur, as well as dyspnea, granulomatous ocular lesions [70] and skin lesions, which are less
frequent [68,69]. Sudden death may be the result of massive hemorrhage secondary to liver
or spleen rupture. In such cases, the birds may exhibit good body condition but frequently
show advanced lesions of tuberculosis. Lameness can be the result of bone dissemination, in
particular to the bone marrow of long bones. Joints can also be affected, and as consequence,
some birds may adapt a sitting position or even show paralysis. There are also reports of
neurological signs, due to the involvement of vertebral or central nervous system [68]. The
lesions of avian tuberculosis are mainly composed by epithelioid cells containing large num‐
bers of bacterium, that may either diffusely infiltrate the organ or form discrete tubercles or
granulomas [68]. In the classical and intestinal forms of the disease, studded greyish-white
to greyish-yellow nodules are frequently observed. The nodules, which appear as tumour-
like masses, bulge from the serosal surface of the intestine and can be palpable. These nod‐
ules may suffer ulceration, and the caseous material within may be discharge into the
intestinal lumen leading to the excretion of mycobacteria in droppings. During dissemina‐
tion, typical caseous lesions, without calcification, are always found in the liver and spleen,
with considerable enlargement of the organs. Nodules are firm but can be incised easily
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since mineralization is rare in avian tuberculosis. Due to this, spleen takes irregular and
“knobbly” appearance. With the disease progression, tubercular nodules in the bone mar‐
row, ovaries and testes, are often seen. Pulmonary lesions, which are a striking feature of
tuberculosis in other species, are rarely observed in birds [68,69]. Pulmonary avian tubercu‐
losis is not common, but it has been reported occasionally in pigeons and water-fowl
[19,65,69]. In the cachexia stage of avian tuberculosis, massive tubercles with large numbers
of bacilli are observed [68,69].
In accordance to the clinical  signs and lesional patterns of tuberculosis in domestic spe‐
cies,  captive,  exotic and wild birds,  including raptors,  generally develop the disseminat‐
ed  form of  avian  tuberculosis,  involving  the  digestive  tract,  liver  and spleen  [66,71,72].
However, some studies reveal that exotic bird species may have lesions in the liver and
spleen without intestinal involvement. These lesions are typical granulomas with a case‐
ous or coagulative necrotic centre and MGC. Acid-fast bacilli are numerous in the central
zone of the tubercle [69].
Infection of birds by Map has been reported, but it often occurs without clinical signs or le‐
sions, despite the typical lesions of paratuberculosis being described in jackdaws (Corvus
monedula), rooks (Corvus frugilegus), and crows (Corvus corone) [46,57]. A study also reported
the occurrence of diarrhea, respiratory signs, hepatomegaly and splenomegaly in a diamond
sparrow (Emblema guttata) with liver granuloma lesions, predominantly composed of lym‐
phocytes and mononuclear cells [73].
4. Diagnostic techniques
The diagnosis of Mac is based on the clinical signs, post mortem gross lesions, and by dem‐
onstrating the presence of acid-fast bacilli using Ziehl-Neelsen staining. This is normally suf‐
ficient to establish the diagnosis [68,69,74,75]. Ante mortem diagnosis is based on clinical
signs, leukograme, serology, culture and also acid-fast stain or biopsy samples of fluids or
organs [76-80]. Radiography and ultrasonography are also useful in the medical evaluation
of birds [79].
4.1. Isolation and identification
The golden standard test for mycobacterium diagnosis is the microbiological culture. Tissue
culture seems to be slightly more sensitive than faecal culture and it allows the infection to
be detected in some animals that had no specific lesions. The culture of bacteria requires
weeks or months of incubation before colony growth occurs. This means that a significant
amount of time is needed before a diagnosis can be made. It is also difficult to isolate bacte‐
ria in culture due to intermittent shedding and a low number of bacilli in faeces and tissues
[81]. M. genavense is extremely difficult to isolate by culture [82,83]. M. avium complex grows
best in media containing eggs or egg yolk and the incubation temperature should be set at
37ºC-40ºC. Culture can be performed in Dorset´s, Herrold´s egg yolk medium, Middlebrook
7H10 and 7H11 or Coletsos medium supplemented with 1% sodium piruvate [68,74,75]. For
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the isolation of Map or M. silvaticum addition of mycobactin is required in all media. Map is
the slowest growing of the culturable mycobacteria [84]. Cultures should be incubated for at
least 8 weeks. Typically, M. avium produces smooth colonies within 2-4 weeks and rough
variants can occur [74]. Culture of Map from faeces or tissues of other animals such as sheep
and goats is less successful due to the “S” strains that usually infect these animals [84]. The
best organs to use for culture are usually liver and spleen but bone marrow can be used if
carcass is decomposed, as it could be less contaminated [74]. Non-sterile specimens need to
be processed with detergent alkali or acid to eliminate rapidly growing microorganisms be‐
fore culture decontamination in order to remove faster growing microbial species. Incuba‐
tion with various decontamination agents such as 0.6-0.75% hexadecylpryridinium chloride
(HPC) or NaOH for 3 hours to overnight, have been used. It is important that decontamina‐
tion does not remove too many viable mycobacterium cells [85,86]. Other methods like sedi‐
mentation and centrifugation can be employed if small numbers of mycobacteria are
expected in the sample [85,87]. Shorter incubation times can be achieved using automated
broth based systems, like liquid culture BACTEC system MGIT 960 [84]. These systems have
been reported to be highly sensitive for culture [88]. For M. genavense the use of BACTEC
system with no additives and pH 6.0 is recommended [89,90]. Middlebrook 7H11 with pH
6.0 supplemented with blood and charcoal is also recommended to promote growth of M.
genavense [91]. In human AIDS patients, laboratory diagnosis of MAC infection is usually
made by the BACTEC blood culture [92]. Conventional biochemical tests for species identifi‐
cation are lengthy and fail to distinguish between M. avium and M. intracelullare [74]. Identi‐
fication of isolates by phenotypic characteristics of majority of clinically relevant
mycobacteria can be based on growth rates, colony pigmentation and biochemical tests such
as niacin production, nitrate reduction, tween 80 hydrolysis arylsulphatase, urease, tellurite
reduction, thiophen-2-carboxylic acid hydrazide sensitivity catalase (qualitative and quanti‐
tative) growth on MacConkey and sodium chloride tolerance [88,93].
Classification of MAC organisms has been made by seroagglutination [19,74]. Seroagglu‐
tination  is  based  on  sugar  residue  specificity  of  surface  glycopeptidolipids,  and  allows
classification of MAC organisms into 28 serovars: 1 to 6, 8 to 11 and 21 are currently as‐
cribed as  M. avium,  while  serovars  7,  12  to  20  and 25  to  M. intracellulare.  However,  no
consensus was achieved on the other serovars [74].  MAC colonies can also be identified
using high performance  liquid  chromatography (HPLC)  for  detecting  mycolic  acid  [19].
HPLC and  the  use  of  monoclonal  antibodies  to  major  serovars  in  ELISA also  facilitate
typing of mycobacteria [19,75].
4.2. Immunological methods
The enzyme linked immunosorbent assay (ELISA) has been used for detecting antimycobac‐
terial antibodies in the serum of ruminants [94]. However, serological assays for detecting
Mycobacterium are problematic. The sensitivity of ELISA is dependent on the stage of the dis‐
ease with a higher sensitivity of the test in case of higher bacterial load. The test can detect
the most severe infections in multibacillar lesions but shows lower sensitivity in animals
with paucibacillar lesions [84]. One important disadvantage is the inability to distinguish be‐
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tween different mycobacterial infections probably due to close antigenic relationship be‐
tween Maa and Map [95].
Tuberculin test is the most widely used method in domestic fowl and the only for which
an international standard for the reagent exists.  Birds are tested by intradermal inocula‐
tion in the wattle with 0.05 ml or 0.1 ml of tuberculin (avian purified protein derivate –
PPD) [74].  A positive reaction is identified as a hot and oedematous swelling at the site
or  by the presence of  a  small  firm nodule of  approximately 5  mm in diameter  after  48
hours  [19].  The  tuberculin  test  and the  haemagglutination test  (stained antigen)  are  the
immunological methods most frequently used for export testing [74]. In the stained anti‐
gen  test  an  antigen  stained  with  1% malachite  green  is  used  for  the  rapid  blood plate
agglutination  test  [96].The  diagnosis  of  Mycobacterial  infections  in  live  wild  animals  re‐
mains a challenge [95]. The comparative cervical tuberculin (CCT) skin test has been ap‐
plied in wild animals such as in cervids [97], but the test presents two major limitations.
It has been proved that CCT cannot detect some stages of infection [98], and wild rumi‐
nants must be captured twice increasing the stress and the risk of accidents for the ani‐
mals and for handlers [95]. Alternative probes like the detection of interferon-γ (IFN- γ)
assay and ELISA,  which employ blood and serum respectively,  could be  an alternative
in  wild animals  [95].  Advantages  of  ELISA and IFN-γ assay is  that  they enable  testing
without handling the animals twice and allow repeated testing, which are important ad‐
vantages  in  case  of  wild  ruminants  [99].  ELISA  detects  humoral  immune  response
whereas  the CCT and IFN-γ assay detect  cellular  immune response [95].  The dominant
response  to  mycobacterial  infections  in  ruminants  is  cell-mediated.  However,  a  recent
study demonstrated that  the  IFN-γ assay may be of  limited usefulness  in  some species
of cervids [100].
4.3. Genetic methods
4.3.1. The contribution of molecular biology to MAC research
During the past several years, many molecular methods have been developed for direct de‐
tection, species identification, and drug susceptibility testing of mycobacteria. These meth‐
ods can potentially reduce the diagnostic time from weeks to days with a higher sensibility.
Molecular biology methods offer new opportunities to differentiate, identify and type bacte‐
rial species and strains. These methods use the variability of nucleic sequences of genes such
as 16S rDNA, beta subunit RNA-ase (rpoB), gyrase (gyrB), rDNA internal transcribed spacer
among other genes. Some of the methods available to differentiate and identify species of
mycobacteria at the DNA sequence level are PCR, PCR-REA, sequencing analysis, spoligo‐
typing and DNA fingerprinting. These methods have been applied to both the “universal”
part of the genome and to specific mycobacterial genes.
Isolation of mycobacterial DNA can be done from living mycobacteria, not only from myco‐
bacterial isolates but also directly from body fluids (sputum, bronchoalveolar lavages, and
bronchial and tracheal aspirates, semen, milk, blood, cerebrospinal fluid), from tissues and
from faeces and can be done using dead mycobacterial cells, namely from formalin-fixed
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and paraffin-embedded tissues and from forensic and archaeological samples [101]. One of
the challenges with molecular detection of Map is to get the genomic DNA out of the bacte‐
ria, which is protected by its thick and waxy cell wall. One method commonly used is the
mechanical disruption by the use of bead beating, a general term for using small beads
mixed with the sample, usually in the presence of a proteolytic enzyme and lysis buffer, to
break tissues or tough cell walls and spores by forceful shaking in a cell disrupter, or “bead
beater”. It is one of several suggested methods to lyse Map [102-105]. Others include homo‐
genized (grinded) sample under liquid nitrogen in a mortar and pestle, combinations of en‐
zymatic treatment, freeze-thaw/boiling and kits for plant DNA purification or for animal
tissues DNA purification [103,105-109]. Commercially available kits, developed for DNA
isolation from different matrices, are commonly used for the rapid isolation and detection of
Map in milk.
4.3.2. Polymerase Chain Reaction (PCR)
The polymerase chain reaction (PCR) is an in vitro method for the amplification of DNA
that was introduced in 1985 [110]. With the performance of a previous reverse transcrip‐
tion step, PCR can also be applied to RNA [111]. Reverse transcription PCR is a modifi‐
cation  of  this  method  used  when  the  initial  template  is  RNA  rather  than  DNA,  the
reverse  transcriptase  enzyme first  converts  the  RNA target  into  a  complementary DNA
copy (cDNA),  that  can be used to  amplify  the  much higher  numbers  of  copies  of  mes‐
senger  or  ribosomal  RNA  than  the  number  of  DNA  copies  present  in  bacteria,  and  it
may detect  specific  expression of  certain genes.  Some modifications to single PCR were
done to  improve results  and were  used for  MAC species  detection,  the  multiplex  PCR,
the  assay  that  include  several  primer  pairs  specific  to  different  DNA  targets  to  allow
amplification and detection of several  pathogens at  the same time, and nested PCR, the
product  from  one  PCR  reaction  serves  as  template  in  a  second  reaction  with  fresh  re‐
agents, thus diluting any PCR inhibiting substances and increasing the sensitivity. As ex‐
ample  differentiation  of  M.  tuberculosis  complex,  M.  avium  and  other  non-tuberculous
mycobacteria  (NTM)  has  been  done  by  using  hybridization  probes  [112].  Targeting  the
16S  rRNA  gene,  3  different  probes,  specific  for  mycobacteria,  M.  tuberculosis  complex
and M. avium,  were  constructed and the  thermal  melting  temperature  (Tm)  was  differ‐
ent  for  M. tuberculosis,  M. kansasii,  M. avium,  M. intracellulare  and M. marinum  allowing
the differentiation. TaqMan PCR assay targeting 65 kD heat shock protein gene has been
used  for  the  detection  of  M.  genavense  and  M.  avium  complex  species  in  avian  tissue
samples [83].
Specific probes are available for the identification of Mycobacterium avium  and Mycobacte‐
rium intracellulare.  Amplification of  the DT1 and DT6 fragments  was considered equally
sensitive for species identification [113]. Recently, numerous isolates suspected of be My‐
cobacterium  intracellulare  were  reclassified  as  Mycobacterium  chimaera  sp.  nov.,  as  part  of
the MAC [114]. Strains of MAC can be identified by serological procedures, on the basis
of differences in the C-mycoside glycopeptidolipids. To date, using 16S rRNA probes, 28
MAC serotypes have been identified from which the serotypes 1–6, 8–11, and 21 belong
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to Maa.  Serovars 7,  12–20,  and 25 have been ascribed to Mycobacterium intracellulare.  Se‐
rovar-1 is the most common organism isolated from birds and from human. Serotypes 1
and 2 are most commonly isolated from domestic birds, and serovar 3 is recovered spor‐
adically from wild birds.  Serotypes 1,  2,  and 3 are considered virulent  for chickens.  Se‐
rotypes  1,  4,  and  8  have  been  reported  to  predominate  among  isolates  from  AIDS
patients [19].
Other approach to the differentiation of MAC strains was obtained with the description of
repetitive insertion sequence IS900 in Map strains and IS901 or IS902 in M. avium subsp. sil‐
vaticum strains [115]. Examination of serotyped strains revealed IS901 only in strains of sero‐
types 1, 2, and 3 [19].
The discovery of insertion sequences in mycobacterial genomes, e.g. IS900 in Map [116],
IS901 [117], IS1245 [118], IS1311 [119] in the MAC strains was a major breakthrough in the
study of mycobacterial infections. When characterized and used in the proper context, the
species-specific IS (insertion sequences) elements can be useful classification tools to distin‐
guish subsets of the MAC [18,120]. However, there are two problems described that can
question their utility for this purpose. First, a number of IS elements have been uncovered in
strains considered to be MAC organisms, but without adequate strain characterization, it is
difficult to judge which organisms harbour such elements. Second, IS elements are by nature
mobile elements, so there is a risk that similar elements are found in unrelated bacteria be‐
cause of mobility to or from MAC organisms [3].
IS900 was the first IS characterized within the Mycobacterium genus [116,121] and is the most
widely used target sequence for detection of Map and presently considered specific for this
agent. The Map genome is reported to have 15 to 20 copies of the insertion element, and the
sequenced strain K-10 has 17 copies [122]. Cousins et al. recommended that restriction diges‐
tion should be used to confirm the profile of the IS of the amplified product [123]. However,
Englund et al. identified a Mycobacterium sp. with an IS900 like sequence in which the re‐
striction sites after amplification with the original primers were identical to the restriction
sites in amplified DNA of Map [124]. Therefore, restriction endonucleases analysis did not
solve the problem of false positives. Englund et al. recommended that a positive IS900 PCR
should be confirmed by subsequent sequencing or by a PCR assay targeting another gene in
Map [124]. In a study performed by Vansnick et al. two sets of newly developed PCR pri‐
mers based on the insertion sequence IS900 and the unique sequence f57 were developed
and the combination of the two PCR assays has proven to be useful for the identification of
Map [125]. Map genome has revealed the presence of 17 IS900, 7 IS1311, and 3 IS1245 inser‐
tion elements. The IS900 element seems unique to Map and has been widely used as a diag‐
nostic tool to detect Map in clinical samples from both animals and humans [5].
The specific DNA sequence IS900 was also used as the target for Map detection in Nested
PCR. In 2002, IS900-nested PCR was used to determine the specificity and sensitivity of a
commercial ELISA test [126]. However, the nested PCR method is now being replaced by
Real-Time PCR [127].
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RFLP analysis of the IS900 element has been used a molecular tool to type Map isolates and
allowed the division of Map into different groups, associated to different host species [3].
The IS900 element is by far the most widely used target for the molecular detection of Map
and has been used in the form of direct PCR [108,125], in situ PCR [128] nested PCR
[126,129,130], and real-time PCR [131-133]. Sequencing of the amplified product for IS900 is
therefore necessary to confirm that the amplicon is truly IS900.
Additional gene loci specific for Map have been identified and suggested for use in diagnos‐
tics: ISMav2 [134], f57 [135], ISMap02 [136], and other Map specific coding sequences [137].
To identify the methods which are best suited for diagnostics, eight single-round and five
nested PCR systems including twelve different primer pairs based on IS900 (9x), 7 ISMav2
(1x), f57 (1x), and locus 255 (1x) sequences were compared by Möbius et al., which conclud‐
ed that stringent selection of IS900-specific primers ensures that IS900 remains a favourite
target sequence for amplification of Map specific loci [138]. A PCR system targeting two dif‐
ferent Map specific regions would have a still higher specificity. The following six single
round PCR-systems were recommended by Möbius et al. [138]: IS900 based PCRs of En‐
glund et al. [139], and Doran et al. [140], the f57 based PCR assay [125], and the locus 255
based PCR assay [137]. However, despite their advantages, such as a hundredfold enhance‐
ment of sensitivity, nested PCR assays bear a high risk of contamination and crossing over
and, therefore, cannot be recommended as a reliable method for routine diagnosis of Map.
The insertion sequence IS901 was discovered by Kunze et al. and shows around 60% se‐
quence homology to IS900 [117]. The stability of IS901 in strains isolated primarily from clin‐
ical material from birds, domestic animals and from the environment is used for the rapid
identification of IS901+ strains using the PCR method. Screening across a larger panel of iso‐
lates revealed that most isolates from birds and some animals contained the element, where‐
as isolates obtained from AIDS patients or the environment did not. Furthermore, it was
found that most bird isolates had similar IS901 patterns [3].
IS1311 was first reported as a GenBank entry in 1994 (U16276) and was subsequently used
for RFLP analyses [119,141]. This element is present in all members of the M. avium subspe‐
cies, including Maa, Mah, and Map [142], and is not present in M. intracellulare [22,141]. The
element itself has 85% sequence identity to IS1245. With the wide range of M. avium hosting
for this element, it is possible that IS1311 represents an “older” IS element which may have
been present prior to subspecies divergence [3]. RFLP analysis of IS1311 and the use of
IS1311 PCR-REA also revealed distinct pattern types, corresponding to different genotype
species strains of M. avium subsp. paratuberculosis [22,142].
The IS1245 was first described in 1995, is present in up to 27 copies in Mycobacterium avium
[118], was presented as having a more restricted range than IS1311, and was found to be sta‐
ble during in vivo and in vitro passage, making it a popular target for restriction fragment
length polymorphism strain typing. It is described as limited to the subspecies of M. avium,
i.e., Maa (that would include Mah), Map subsp. paratuberculosis, and M. avium subsp. silvati‐
cum. By PCR analysis, this element was not found in M. intracellulare or in 17 other mycobac‐
terium species [3]. Standardization of IS1245 RFLP analysis was proposed in 1998 as a tool
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for MAC molecular epidemiology [143]. Some M. avium isolates have been documented as
being IS1245 negative, but only a few such reports have presented further documentation of
strain identity by a sequence-based method [144]. Beggs et al. found IS1245 in strains of M.
intracellulare, demonstrating that the element is present in other species of the M. avium com‐
plex [144]. In some reports, IS1245-negative isolates have been described that contain an
hsp65 sequence identical to that of M. avium but that differs from M. avium in other taxo‐
nomic targets, such as the 16S rRNA gene and the ITS sequence [3].
Other identification methods of M. avium species or its subspecies are based on 16S rDNA
[145], PCR-REA (Restriction Endonuclease Analysis) [146], sequence analysis of hsp65 [8] or
a strategy based on large sequence polymorphisms [147]. Semret et al. evaluating the distri‐
bution of genomic polymorphisms across a panel of strains, verified that it was possible to
assign unique genomic signatures to host-associated variants and based on these polymor‐
phisms proposed a simple PCR-based strategy that can rapidly type M. avium isolates into
these subgroups [147].
The sequence of the 16S rDNA gene is specific at the species level and is also a stable prop‐
erty of microorganisms. Wilton and Cousins described a method for the simultaneous iden‐
tification of genus, species and strains of Mycobacterium sp. using conserved and variable
sequences of the 16S rDNA gene [145]. Comparing the 16S rDNA sequences of mycobacteri‐
al pathogens, they found variable regions specific for individual species and used the infor‐
mation to develop a duplex amplification system, which makes it possible to identify the
genus Mycobacterium, and the species M. a. avium and M. intracellulare. If combining the pri‐
mers for 16S rDNA with primers specific to the gene that encodes the secretion protein
MPB70 (specific for Mycobacterium tuberculosis complex) this system permits the detection
and identification of clinically important mycobacteria in one single PCR. The disadvantage
of this method is that it does not distinguish between M. a. avium and M. a. paratuberculosis.
Combining PCR amplification of the 16S rDNA gene and subsequent restriction analysis we
have the PCR-REA (or PRA) method. Using the 16S rDNA gene primers according to Thier‐
ry et al. and the resulting PCR products, 1 300 bp in size digested with Rsa I it is possible to
distinguish species of MAC (M. a. avium serotypes 1–3, 8–11 and 21, M. a. paratuberculosis)
and M. intracellulare (serotypes 7, 12–20, 22–28) [148].
Standard (housekeeping) genes offer a higher level of sequence variation than do ribosomal
genes but are nonetheless useful for taxonomic purposes due to the relative sequence con‐
servation imposed to maintain function. In this category, the stress protein gene hsp65 is a
preferred target for mycobacterial identification to the species level, having been routinely
used in diagnostics since the development of rapid PCR-restriction enzyme analysis (PRA)
methods. The dnaJ gene encodes a stress chaperone protein and is highly conserved among
the bacterial genera [149]. Morakova et al. designed primers specific for the dnaJ gene in the
M. avium species that allow amplification of the dnaJ gene in all isolates of all M. avium sub‐
species and the authors suggest using them as an internal standard in the multiplex PCR to
control inhibition of the amplification, and consequently false negatives, because are highly
specific for at least M. avium [108]. The same team designed a fast and specific PCR strategy
for the detection and differentiation of M. avium subspecies for use in routine veterinary di‐
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agnosis [108]. They have developed a multiplex PCR based on IS900, IS901, IS1245 and the
dnaJ gene. This method allows the detection of M. a. paratuberculosis, M. a. hominissuis and M.
a. avium/M. a. silvaticum in one PCR reaction (PCR multiplex) and theoretically enables the
detection of mixed infections of M. a. paratuberculosis and M. a. avium or M. a. paratuberculosis
and M. a. hominissuis. The sensitivity of this multiplex PCR is 103 CFU for each bacterial
strain in one PCR reaction, which also enabled the use of this test directly for DNA isolated
from the tissue of the heavily infected sheep.
Shin et al. designed a five-target multiplex PCR to discriminate MAC organisms isolated.
This MAC multiplex was designed to amplify a 16S rRNA gene target common to all Myco‐
bacterium species, a chromosomal target called DT1 that is unique to Maa serotypes 2 and 3,
to M. avium subsp. silvaticum, and to M. intracellulare, and three insertion sequences, IS900,
IS901, and IS1311. The results for the pattern of amplification allowed to determine whether
isolates were mycobacteria, or members of MAC, and to classify them into one of the three
major MAC subspecies, Map, Maa, Mah [18].
5. Public health concerns
Zoonotic aspects of mycobacteria transmitted by the environment and wildlife highlights a
major health problem. MAC causes a variety of disorders including tuberculosis-like diseas‐
es in animals and in human immunocompetent or immunocompromised patients. Suscepti‐
bility to mycobacterial infections depends of risk factors since they are ubiquous in the soil
and water [150]. Human exposure to mycobacterium present in wildlife and in nature can
occur by a variety of routes. Humans are continuously exposed at a low level (50 to 5000
bacilli per day). Contact with water, municipal or natural are also important routes for my‐
cobacteria infection. Birds are major excretors of the agent in their faeces and the bacteria
can persist in the soil and in water for long [1].
Healthy humans have a low susceptibility to MAC infection and only a very small percent‐
age of mycobacteria progress trough to infection, but in immunocompromised individuals
infected with HIV or leukaemia patients, treated with steroid therapy, chemotherapy or oth‐
er immunosuppressive medication, should be carefully considered regarding their possibili‐
ty to come in contact with birds with mycobacterial infection [1,151]. Prior to the
introduction of highly active antiretroviral treatment more than 40% of patients developed
M. avium complex bacteriemia two years after the AIDS diagnosis [152] and a disseminated
MAC infection was found in as much as 50% of autopsied AIDS patients [153,154]. This has
predominantly been attributed to the impairment of the adaptative part of the immune sys‐
tems in HIV-1 infected individuals due to the loss of CD4+ T cells, as the susceptibility to
opportunistic infections including M. avium infection is correlated with a decline in this cell
type [155]. MAC usually produces clinical disease only when CD4+ are very low (< 50 cells/
ml), which is seen in 4 to 5 per cent of HIV infected patients [88]. A recent study showed that
exposure of dendritic cells to HIV-1 promotes or facilitates the intracellular growth of M.
avium [153]. Signs and symptoms associated with MAC disease in AIDS cases are persistent
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high grade fever, high sweats, anaemia and weight loss in addition to nonspecific symptoms
of malaise, anorexia, diarrhea, myalgia and occasional painful adenophaty [88]. Epidemiolo‐
gy of MAC complex in patients without HIV infection remains somewhat difficult to deter‐
mine since the disease is relatively uncommon, it is not a reportable health event and
environmental exposure varies greatly according to the geographic region [156]. In an epide‐
miological survey in USA from 2000 to 2003 performed in [156] in patients without HIV in‐
fection the rate of positive non-tuberculous cultures was 17.7 per 100,000. Surveys
conducted in Europe estimated the rate of disease anywhere in the human body to be 0.8-3.1
per 100,000 [157,158]. In a recent study, Bodle et al. estimated the incidence of non-tubercu‐
lous mycobacteria in the respiratory tract disease in 2.0 per 100,000 and the disease in any‐
where in the human body in 2.7 per 100,000 [156]. Another recently published study showed
that the patient´s lung disease was likely acquired by inhalation of aerosols while showering
[159]. M. avium may reach the lungs by aspiration because a considerable percentage of pa‐
tients with non-tuberculous mycobacteria (NMT) disease have been found to experience
gastroesophageal reflux disease [160,161].
Disease patterns of MAC are different in immunocompromised patients. In adults, infection
is mainly pulmonary [1,151]. MAC is the most common of the nontuberculous mycobacteria
found in apparently healthy children [162] and it’s infection is characterized by a chronic
granulomatous lymphadenopathy in the neck region that preferably is treated by excision of
the affected lymph node [162,163]. The main hypothesis of infection is that oral contact with
M. avium-infected water courses causes lymphadenitis in the head and neck region in chil‐
dren [162,164]. Among the members of MAC, Maa is predominant (87-98%) in AIDS patients
and induces disseminated mycobacteriemia rather than restrict the bacteria to the lungs [1].
Since the advent of AIDS, HIV has become the major risk factor for MAC infection. In AIDS
patients the main route of infection is the gastrointestinal tract and M. avium is naturally tol‐
erant to the low pH that exists in the stomach [19,165]. Regarding therapeutics, M. avium is
of special concern because drugs commonly used from treating tuberculosis in humans are
not effective [166] and MAC strains are resistant to isoniazid, the most popular anti-tubercu‐
losis drug [19,167]. Preexisting pulmonary conditions, patients with current illness or immu‐
nosuppressive medication are the most important risk factors for MAC infection amongst
patients without HIV infection. MAC was also reported as the most common pathogen caus‐
ing post transplant non-tuberculous mycobacteria disease [156]. Other factors are local trau‐
mas and surgical procedures injuries [168]. Chronic obstructive pulmonary disease,
emphysema, pneumoconiosis, aspiration due to oesophageal disease, previous gastrectomy
and chronic alcoholism are some of the conditions which have been linked to disease
[88,154]. Disseminated MAC infection is more frequent in caucasians compared with His‐
panic or African-americans individuals. However, there are no differences related with age
[169,170]. Infection is more frequent in men than in women, particularly in homosexual and
bisexual men, when compared to other HIV risk categories.
The zoonotic potential of Map has been debated for almost a century because of similarities
between Johne´s disease in cattle and Crohn´s disease in humans. A quarter century later
since Map was first proposed as an etiologic agent in Crohn´s disease based on the isolation
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of the organism from several patients the association as a causative agent or in an incidental
away remains unresolved. Milk and water are potential sources for acquiring Map infection
[171]. However, only a few samples of milk, positive by PCR for the presence of Map have
yielded positive results in culture, suggesting that Map remains undetectable probably be‐
cause the low number of viable Map in samples [172]. Published reports indicate that Map
may not be completely inactivated by pasteurization of milk [173]. Serological response to
Map in humans is also not conclusive [172]. Traditional methods of detecting bacteria, cul‐
ture and stain are largely ineffective in detecting Map in humans. Bacteria are very difficult
to culture and Map is able to exist in a spheroplast (cell wall deficient form) in humans so it
cannot be identified by Ziehl-Neelsen staining [174-176]. Polymerase chain reaction has
identified Map in greater than 90% of biopsy specimens from Crohn´s patients [177] and via‐
ble Map was detected in peripheral blood and serum in a higher proportion of individuals
with Crohn’s disease [178,179]. However, culture of Map from human specimens is a contro‐
versial question since some authors pointed out the difficulty of culturing Map [180,181]. At
this moment is not possible to know if Map is a primary etiological agent or secondary in‐
vader and further research is need to understand the possible links between this agent and
Crohn disease [1].
There is a recent interest in Map as an immune trigger of several autoimmune diseases
[182,183]. Environmental agents are postulated to trigger autism. Recently, a theory propos‐
ing a mechanism by which Map triggers autism through molecular mimicry to the heat
shock protein HSP65, which stimulates antibodies that cross react with myelin basic protein,
a common feature of autism [184]. Another recent study has associated the presence of Map
with Blau syndrome, an autossomal dominant, and systemic inflammatory disease. The mu‐
tations of Blau syndrome are on the same gene on chromosome 16 (CARD 15) that confers
susceptibility to Crohns´disease [185]. Map was also implicated in sarcoidosis [186,187],
which is a multisystemic granulomatous disease with many features in common with myco‐
bacterial infection, and that, like Crohn´s disease, can be mimicked by slow bacterial infec‐
tions [188,189].
Map was also linked to ulcerative colitis, irritable bowel syndrome, autoimmune (type 1)
diabetes, Hashimoto thyroiditis and multiple sclerosis [179,184]. Increasing evidence sug‐
gests a role for Map in autoimmune (type I) diabetes. It is postulated that this bacterium acts
via molecular mimicry between its antigens (HSP65) and the pancreatic enzyme glutamic
acid decarboxylase (GAD) [190-195].
6. Conclusion
MAC comprises slow growing mycobacteria that are ubiquitous in the environment (soil
and water), and have a wide source range, causing disease in various domestic and wild
mammals and birds. MAC can affect a wide-range of wild animals, but little has been pub‐
lished up to the moment on the clinical signs, which are rarely exhibited or not documented.
When present, the occurrence of clinical signs and lesions is highly variable in timing,
though often similar to those of their domesticated counterparts.
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The evidence for the zoonotic potential should not be neglected particularly in immunocom‐
promised patients, both humans and animals.
Recent reports, suggesting an association between MAC and autoimmune and other chronic
human diseases, alert to the importance of developing new studies on MAC biology, molec‐
ular diagnosis and epidemiology.
Research to understand the impact of MAC in public health is needed as well as the deter‐
mination of transmission routes between humans and wildlife, which requires interdiscipli‐
nary collaboration among medical, veterinary and other public health officials.
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N, Coelho A, Pinto M, editors. Renal Lesions in Deer (Cervus elaphus) - Mycobacteri‐
um avium subsp. paratuberculosis Involvelment. 30th Meeting of the European Soci‐
ety of Veterinary Pathology; 2012 September 5th to 8th Léon,Spain.
[42] de Lisle G, Joyce MA, Yates GF, Wards BJ, Hoyle FP. Mycobacterium avium Infection
in a Farmed Deer Herd. New Zealand Veterinary Journal. 1995;43(1) 1-3.
[43] Griffin J. The aetiology of tuberculosis and mycobacterial diseases in farmed deer.
Irish Veterinary Journal. 1988;42(1) 23-26.
[44] Machackova-Kopecna M, Bartos M, Straka M, Ludvik V, Svastova P, Alvarez J, Lam‐
ka J, Trcka I, Treml F, Parmova I, Pavlik I. Paratuberculosis and avian tuberculosis
infections in one red deer farm studied by IS900 and IS901 RFLP analysis. Veterinary
Microbiology. 2005;105(3-4) 261-268.
[45] Crawford GC, Ziccardi MH, Gonzales BJ, Woods LM, Fischer JK, Manning EJB, Ma‐
zet JAK. Mycobacterium avium subspecies paratuberculosis and Mycobacterium
avium subsp. avium Infections in a Tule Elk (Cervus elaphus nannodes) Herd. Jour‐
nal of Wildlife Diseases. 2006;42(4) 715-723.
[46] Beard PM, Daniels MJ, Henderson D, Pirie A, Rudge K, Buxton D, Rhind S, Greig A,
Hutchings MR, McKendrick I, Stevenson K, Sharp JM. Paratuberculosis Infection of
Nonruminant Wildlife in Scotland. Journal of Clinical Microbiology. 2001;39(4)
1517-1521.
[47] Corn JL, Manning EJB, Sreevatsan S, Fischer JR. Isolation of Mycobacterium avium
subsp. paratuberculosis from Free-Ranging Birds and Mammals on Livestock Prem‐
ises. Applied and Environmental Microbiology. 2005;71(11) 6963-6967.
[48] Deutz A, Spergser J, Wagner P, Rosengarten R, Köfer J. Mycobacterium avium subsp.
paratuberculosis in wild animal species and cattle in Styria/Austria. Berliner und
Munchener Tierarztliche Wochenschrift. 2005;118(7-8) 314-320.
[49] Machackova M, Matlova L, Lamka J, Smolik J, Melicharek I, Hanzlikova M, Docekal
J, Cvetnic Z, Nagy G, Lipiec M, Ocepec M, Pavlik I. Wild boar (Sus scrofa) as a Possi‐
ble Vector of Mycobacterial Infections: Review of Literature and Critical Analysis of
Data from Central Europe Between 1983 to 2001. Veterinarni Medicina. 2003;48(3)
51-65
Mycobacterium avium Complex in Domestic and Wild Animals
http://dx.doi.org/10.5772/54323
115
[50] Cousins DV, Williams SN, Hope A, Eamens GJ. DNA Fingerprinting of Australian
Isolates of Mycobacterium avium subsp paratuberculosis using IS900 RFLP. Austral‐
ian Veterinary Journal. 2000;78(3) 184-190.
[51] Kopecna M, Ondrus S, Literak I, Klimes J, Horvathova A, Moravkova M, Bartos M,
Trcka I, Pavlik I. Detection of Mycobacterium avium subsp. paratuberculosis in Two
Brown Bears in the Central European Carpathians. Journal of Wildlife Diseases.
2006;42(3) 691-695.
[52] McClure HM, Chiodini RJ, Anderson DC, Swenson RB, Thayer WR, Coutu JA. Myco‐
bacterium paratuberculosis Infection in a Colony of Stumptail Macaques (Macaca
arctoides). Journal of Infectious Diseases. 1987;155(5) 1011-1019.
[53] Zwick LS, Walsh TF, Barbiers R, Collins MT, Kinsel MJ, Murnane RD. Paratuberculo‐
sis in a Mandrill (Papio sphinx). Journal of Veterinary Diagnostic Investigation.
2002;14(4) 326-328.
[54] Beard PM, Rhind SM, Buxton D, Daniels MJ, Henderson D, Pirie A, Rudge K, Greig
A, Hutchings MR, Stevenson K, Sharp JM. Natural Paratuberculosis Infection in Rab‐
bits in Scotland. Journal of Comparative Pathology. 2001;124(4) 290-299.
[55] Beard RM, Henderson D, Daniels MJ, Pirie A, Buxton D, Greig A, Hutchings MR,
McKendrick I, Rhind S, Stevenson K, Sharp JM. Evidence of Paratuberculosis in Fox
(Vulpes vulpes) and Stoat (Mustela erminea). Veterinary Record. 1999;145(21)
612-613.
[56] Florou M, Leontides L, Kostoulas P, Billinis C, Sofia M, Kyriazakis I, Lykotrafitis F.
Isolation of Mycobacterium avium subspecies paratuberculosis from Non-Ruminant
Wildlife Living in the Sheds and on the Pastures of Greek Sheep and Goats. Epidemi‐
ology and Infection. 2008;136(5) 644-652.
[57] Nugent G, Whitford EJ, Hunnam JC, Wilson PR, Cross ML, de Lisle GW. Mycobacte‐
rium avium subsp. paratuberculosis Infection in Wildlife on Three Deer Farms with a
History of Johne's Disease. New Zealand Veterinary Journal. 2011;59(6) 293-298.
[58] Matos A, Figueira L, Martins M, Matos M, Álvares S, Pinto M, Coelho A. Disseminat‐
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